A fully integrated SNP genotyping system for hereditary hearing-loss detection

Area of Science:

• Genetics
• Biotechnology
• Medical Diagnostics

Background:

• Hereditary hearing loss is a common neurosensory disorder requiring early detection.
• Genetic screening, particularly for single nucleotide polymorphisms (SNPs), is crucial for identifying at-risk newborns.
• Existing methods can be time-consuming and require complex laboratory procedures.

Purpose of the Study:

• To develop and evaluate a fully integrated, automated SNP genotyping system for hereditary hearing loss.
• To assess the system's performance, including specificity, sensitivity, and stability.
• To validate the system's accuracy in detecting known deafness-associated mutations in clinical samples.

Main Methods:

• Construction of a self-contained fluidic cassette system for automated sample processing.
• Integration of blood cell lysis, nucleic acid extraction, reaction mixture distribution, chamber sealing, and multiplex allele-specific polymerase chain reaction (KASP).
• Genotyping of 13 clinical samples for seven hotspot mutations in *MT-RNR1*, *GJB2*, and *SLC26A4* genes.

Main Results:

• The automated system successfully integrated all detection steps within a 3-hour timeframe.
• The system demonstrated high specificity, sensitivity, and stability in performance evaluations.
• Genotyping results from the cassette system showed 100% concordance with traditional Sanger sequencing.

Conclusions:

• The developed integrated SNP genotyping system provides an accurate and efficient method for hereditary hearing loss screening.
• The automated fluidic cassette system is suitable for rapid genetic screening of newborns.
• This technology holds significant potential for early intervention strategies in managing inherited hearing loss.